Yes, curl can be targeted in cancer treatment. By understanding the molecular pathways that drive curl, researchers can develop drugs that specifically inhibit these processes. For example, targeting the cytoskeletal proteins involved in cell movement can potentially reduce cancer cell invasion and metastasis. Additionally, therapies that reverse structural changes in cancer cells may restore normal cell function and increase sensitivity to treatment.
